2024-10-14 11:20:00
The 12 de Octubre Hospital in Madrid has used nuclear medicine therapy for the first time to treat non-melanoma skin cancers, such as carcinomas. It is a resin that contains a radiopharmaceutical that targets the cancerous lesion.
<img width="1170" height="752" class="attachment-newpress-featured-large size-newpress-featured-large wp-post-image lazyload" alt="Terapia de medicina nuclear contra el cáncer de piel no melanoma" decoding="async" fetchpriority="high" data-attachment-id="358456" data-permalink="https://efesalud.com/medicina-nuclear-cancer-piel-no-melanoma-hospital-12-octubre/medicina-nuclear-cancer-piel-paciente/" data-orig-file="https://efesalud.com/wp-content/uploads/2024/10/medicina-nuclear-cancer-piel-paciente.jpg" data-orig-size="1920,1293" data-comments-opened="0" data-image-meta="{"aperture":"1.7","credit":"","camera":"Galaxy S23 Ultra","caption":"","created_timestamp":"1717586858","copyright":"","focal_length":"6.3","iso":"200","shutter_speed":"0.01","title":"","orientation":"0"}" data-image-title="medicina-nuclear-cancer-piel-paciente" data-image-description="" data-image-caption="
Photo of a patient with non-melanoma skin cancer undergoing pioneering nuclear medicine therapy. Photo provided by the 12 de Octubre Hospital in Madrid.
” data-medium-file=” data-large-file=” tabindex=”0″ role=”button” src=” srcset=” 1170w, 370w” data-sizes=”auto” data-eio-rwidth=”1170 ” data-eio-rheight=”752″/>
Photo of a patient with non-melanoma skin cancer undergoing pioneering nuclear medicine therapy. Photo provided by the 12 de Octubre Hospital in Madrid.
This nuclear medicine technique represents an alternative for skin cancer patients with certain characteristics and who are not candidates for conventional therapies, such as surgery. The profile is of an elderly patient.
The technique has few adverse effects and high positive response rates, as well as not requiring anesthesia and hospitalization.
This is how this nuclear medicine technique is applied in skin cancer
It consists in the application of a thin layer of resin labeled with the radiopharmaceutical Rhenio-188, which acts in contact with the lesion, reports the October 12 Hospital.
Each person receives the individually calculated radioactive dose. Administered in one session
unique and painless, with the aid of a brush applicator on a transparent dressing that covers the lesion, following radioprotection measures.
The time varies between 30 and 180 minutes and then the patient can be discharged, requiring only hydration and sun protection treatments in the area of the lesion.
Dermatologist María del Carmen García Donoso. Video provided by the 12 de Octubre Hospital in Madrid
No evidence of toxicity
The therapy was first applied in June this year to two people who, after three months of follow-up, had no evidence of disease in non-melanoma skin cancer.
Furthermore, they found no toxicity resulting from it, as well as a satisfactory aesthetic result.
According to the aforementioned hospital center, this nuclear technique consumes fewer hospital resources, has few adverse effects and high efficacy rates.
Recent studies show minimal recurrence rates, making it a technique with similar or even superior efficacy to surgery, which is the standard treatment.
Its management is undertaken by professionals from the Nuclear Medicine Service of this Hospital, in close collaboration with the Dermatology Service, which is responsible for the selection of
candidates and planning.
#Nuclear #medicine #therapy #nonmelanoma #skin #cancer